First Light Asset Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History

First Light Asset Management, LLC

$1.28 Billion
Q1 2024

A detailed history of First Light Asset Management, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, First Light Asset Management, LLC holds 790,446 shares of RARE stock, worth $32.4 Million. This represents 2.89% of its overall portfolio holdings.

Number of Shares

790,446

Previous 744,665 6.15%

Holding current value

$32.4 Million

Previous $35.6 Million 3.64%

% of portfolio

2.89%

Previous 2.97%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$43.02 - $53.69 $1.97 Million - $2.46 Million	45,781 Added 6.15%	790,446 $36.9 Million
Q4 2023 Feb 14, 2024	BUY	$31.73 - $49.19 $4.91 Million - $7.61 Million	154,702 Added 26.22%	744,665 $35.6 Million
Q2 2023 Aug 14, 2023	BUY	$37.35 - $52.15 $13.2 Million - $18.5 Million	354,186 Added 150.22%	589,963 $27.2 Million
Q1 2023 May 15, 2023	BUY	$36.99 - $48.71 $54,671 - $71,993	1,478 Added 0.63%	235,777 $9.45 Million
Q4 2022 Feb 14, 2023	SELL	$33.72 - $46.33 $7.4 Million - $10.2 Million	-219,495 Reduced 48.37%	234,299 $10.9 Million

Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $52,907 - $87,569	1,324 Added 0.29%	453,794 $18.8 Million
Q2 2022 Aug 12, 2022	BUY	$45.8 - $85.4 $685,076 - $1.28 Million	14,958 Added 3.42%	452,470 $27 Million
Q1 2022 May 13, 2022	BUY	$62.2 - $84.4 $1.63 Million - $2.21 Million	26,199 Added 6.37%	437,512 $31.8 Million
Q4 2021 Feb 14, 2022	SELL	$73.71 - $87.86 $2.2 Million - $2.62 Million	-29,846 Reduced 6.77%	411,313 $34.6 Million
Q3 2021 Nov 12, 2021	BUY	$77.92 - $102.4 $16.5 Million - $21.7 Million	211,913 Added 92.44%	441,159 $39.8 Million
Q2 2021 Aug 13, 2021	BUY	$92.19 - $115.71 $1.09 Million - $1.36 Million	11,787 Added 5.42%	229,246 $21.9 Million
Q1 2021 May 17, 2021	BUY	$106.9 - $167.73 $381,846 - $599,131	3,572 Added 1.67%	217,459 $24.8 Million
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $2.44 Million - $5.13 Million	28,917 Added 15.63%	213,887 $29.6 Million
Q3 2020 Nov 13, 2020	SELL	$72.98 - $90.0 $3.79 Million - $4.68 Million	-51,988 Reduced 21.94%	184,970 $15.2 Million
Q2 2020 Aug 14, 2020	SELL	$46.91 - $78.22 $4.96 Million - $8.26 Million	-105,645 Reduced 30.84%	236,958 $18.5 Million
Q1 2020 May 15, 2020	BUY	$33.8 - $62.9 $5.68 Million - $10.6 Million	168,166 Added 96.41%	342,603 $15.2 Million
Q4 2019 Feb 14, 2020	SELL	$36.08 - $45.83 $188,409 - $239,324	-5,222 Reduced 2.91%	174,437 $7.45 Million
Q3 2019 Nov 14, 2019	SELL	$42.5 - $63.11 $15,215 - $22,593	-358 Reduced 0.2%	179,659 $7.69 Million
Q2 2019 Aug 14, 2019	BUY	$54.93 - $74.36 $9.89 Million - $13.4 Million	180,017 New	180,017 $11.4 Million

Others Institutions Holding RARE

# of Institutions

286

Shares Held

78.6M

Call Options Held

570K

Put Options Held

228K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.87B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Light Asset Management, LLC with notifications on news.

Account

First Light Asset Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History